Pediatric Infections - AOM Flashcards

1
Q

Acute otitis media (AOM) Background

  • More than 5 million AOM cases each year in US children
  • Leads to > 10 million antibiotic prescriptions annually
  • Most ___ indication for antibiotics in children
  • 60% have at least one episode by 3 years, ~25% have ≥3 episodes of AOM
A
  • common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AOM Risk Factors

◦ ___ exposure
◦ ___ feeding (vs breastfeeding)
◦ Immunization status
◦ Atopy
◦ ___ attendance
◦ ___ gender
◦ Family history - Sibling or parent w/ > 3 episodes AOM or tube surgery
◦ Onset of first episode before __ - ___ months of age (earlier = higher risk)
- Lower socioeconomic status
- Race: non-white/hispanic
- Congenital anomalies
- Immune deficiency

A
  • smoke
  • formula
  • daycare
  • male
  • 6-12
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Classification

Otitis media with effusion (OME)
- Middle ear fluid is ___ ; no signs of acute infection
- Antibiotics not indicated and not beneficial

Acute otitis media (AOM)
- Bacterial infection likely
- Antibiotics indicated if ___

A
  • sterile
  • symptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anatomical Differences

Infant eustachian tube is ___, more flexible and more ___ vs. adult

A
  • shorter
  • horizontal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathogenesis

1) Ineffective aeration of middle ear space = eustachian tube ___
2) Inflammation and edema of mucosal linings and ___ of eustachian tube lumen
3) Trapped air creates ___ reversing flow of secretions, drawing fluid into middle ear
4) Bacteria multiply in fluid and stimulate inflammation

pathologic bacteria are isolated from __ - __ % of well documented cases of AOM

A

1) dysfunction
2) narrowing
3) vacuum

65-75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Microbiology AOM

___ - 35-45%
___ - 25-30%
___ - 20-25%
no pathogen - 20-30%
Streptococcus pyogenes (strep A) - 2-4%

Less common
- Staphylococcus aureus
- Gram-negative organisms

A
  • Haemophilus influenzae
  • Streptococcus pneumoniae
  • Moraxella catarrhalis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Timeline of Pneumococcal Vaccination

Previous PCV versions:
* PCV7 = 2000 (DSC 2010)
* PCV13 = 2010 (DSC 2023)

Currently in peds can use either:
* PCV __ = 2022
* PCV __ = 2023
* Cover more serotypes

Usually given at 2, 4, 6, 12-15 months

A
  • 15
  • 20
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Influence of Pneumococcal Vaccination

Serotype maturity takes __ + years after
new vaccine introduced

A

5+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

AOM Clinical Manifestations

  • Otalgia (ear ___ )
  • Holding or tugging at ear
  • Fever
  • Irritability
  • Poor feeding/anorexia
  • Disrupted sleep
  • Malaise
  • Otorrhea (ear ___ )
  • Sometimes ___
A
  • pain
  • discharge
  • asymptomatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Diagnosis of AOM

Visualize tympanic membrane (TM)
- ___
- Cloudy or ___ effusion
- ___ (normal moves in response to pressure)

Middle ear fluid culture via tympanocentesis
(infrequent) - eek

A
  • bulging
  • purulent
  • immobile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diagnosis of AOM

Diagnosis requires:
◦ ___ onset
◦ Middle ear ___
◦ ___ of middle ear inflammation

A
  • acute
  • effusion
  • symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Severity

Non-severe
◦ Mild ___
AND
◦ Fever __ 39 ̊C in past 24 hours

Severe
◦ Moderate to severe ___
OR
◦ Fever __ 39 ̊C

A
  • otalgia
  • <
  • otalgia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Criteria for Observation vs. Treatment

pretty much going to treat everyone immediately except the below: (observe option)

non-severe, unilaterial
- __ month - __ years
- ≥ __ years

non-severe, bilateral
- ≥ __ years

A
  • 6, 2
  • 2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of AOM

Observation
◦ Deferment of antibiotics for __ - __ hours
◦ Watch for resolution of symptoms
◦ Provide symptomatic relief

Decision to observe based on:
◦ Child’s age
◦ Diagnostic certainty
◦ Illness severity
◦ Assurance of follow-up

A
  • 48-72
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Observation Failure

Must ensure close follow-up and prompt access to medical care if no improvement

What to do if observation fails
◦ Communicate with physician
◦ Begin antimicrobial therapy
◦ Continue symptomatic therapy

___ - __ Antibiotic Prescription (SNAP)
◦ Parents allow __ - __ days for infection to resolve
◦ If symptoms persist or worsen, fill prescription

A

Safety-Net
- 1-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Resistance

Streptococcus pneumoniae
◦ __ % of strains are penicillin resistant
◦ Due to alterations in PBP
◦ Overcome by ___ concentrations of antibiotic at site (high-dose amox) - yay

Haemophilus influenzae & Moraxella catarrhalis
◦ 40-50% of H. flu strains and almost all M. catarrhalis strains produce ___ (amoxicillin resistant)
◦ Overcome by addition of ___ ___ (such as in amox/clav)

A
  • 50%
  • higher
  • B-lactamase
  • B-lactamase inhibitor
17
Q

AOM Treatment

First Line:
- ___ __ - __ mg/kg/day divided Q12H x __ - __ days

Advantages:
◦ In middle ear, high dose amox concentrations exceeds MIC of ___ strains resistant to penicillin (all intermediate and many highly resistant)
◦ Safe, effective, inexpensive
◦ Half-life __ - __ hours in middle ear (vs 1 hr in serum)

A
  • Amoxicillin, 80-90, 5-10
  • S. pneumoniae
  • 4-6
18
Q

AOM: When do we NOT use amoxicillin?

  • Known ___
  • Treatment failure
  • Amoxicillin in last ___ days
  • Allergy
  • Concurrent ___
A
  • resistance
  • 30
  • conjunctivitis
19
Q

Amoxicillin-clavulanate (Augmentin)

  • 2nd line if amoxicillin failure
  • 1st line if amox in last ___ days/ ___
    Dose: __ mg/kg/day amox component divided Q12H

Advantages:
◦ Additional coverage for ___ -producing organisms

Disadvantages:
◦ May be more expensive
◦ ___ associated with clavulanate
◦ Dose clavulanate at ≤ __ mg/kg/day

A
  • 30, conjunctivitis
  • 90
  • ß-lactamase
  • Diarrhea
  • 10
20
Q

Amoxicillin-clavulanate (Augmentin)

Many available forms
◦ 125 mg amox/31.25 mg clav/5 mL
◦ 200 mg amox/28.5 mg clav/5 mL
◦ 250 mg amox/62.5 mg clav/5 mL
◦ 400 mg amox/57 mg clav/5 mL
◦ 600 mg amox/42.9 mg clav/5 mL
◦ ES-600

Which one do we choose?

A
  • 600 mg amox/42.9 mg clav/5 mL
21
Q

AOM - Oral Cephalosporins

2nd line (if allergy may be 1st)

___ :
◦ 3rd gen cephalosporin
◦ 10 mg/kg/day divided Q12H
◦ Tastes ___
◦ Better bioavailability; may work better than ___ but can be harder to get

___ (Omnicef®)
◦ 3rd gen cephalosporin
◦ 14 mg/kg/day divided Q12H to Q24H
◦ Tastes ___
- ___ bioavailability

Cefuroxime → liquid must be compounded

A
  • Cefpodoxime, bad
  • Cefdinir, good, poor
22
Q

AOM Allergy

Cross-reactivity highest between penicillins and ___ generation cephalosporins
◦ Much lower w/ 2nd and 3rd generation cephalosporins; cefdinir, cefuroxime,
cefpodixime, ceftriaxone structurally very different from PCN
Reaction rate of ~0.1%
May skin test to assess

23
Q

AOM

Ceftriaxone (Rocephin)

For ___ cases if
◦ Oral treatment not option
◦ Initial oral treatment fails

Dosing
◦ 50 mg/kg daily IM
◦ ___ dose initial therapy
◦ ___ doses treatment failure

Advantages
◦ Broad spectrum
◦ As effective as ___ days of amoxicillin
◦ Compliance

Disadvantages
◦ Injection site pain
◦ Cost
◦ Avoid in < ___ month of age
◦ Cautions: ___ co-administration and ___

A
  • severe
  • 1, 3
  • 10
  • 1
  • calcium, C. diff
24
Q

AOM Alternartive Agents

Culture if repeated failure; may need alternative if cephalosporin anaphylaxis

___ (30-40 mg/kg/day divided TID)
◦ Not active against H. influenza
◦ May be option vs. PCN-resistant S. pneumoniae

___ or ___
◦ $$$, may be an option against certain resistant organisms
◦ Quinolones can lead to collateral resistance

___ (erythromycin and azithromycin) limited efficacy vs. H. influenza and S.pnuemoniae
- Azithromycin = resistance

___ / ___ = S. pneumo resistance; would not use for treatment failure (may be allergy option)

A
  • Clindamycin
  • levofloxacin, linezolid
  • macrolides
  • TMP/SMX
25
Q

AOM Duration: Under 2 years old

520 children aged 6-23 months randomized to amox-clav for 10 days or 5 days + 5 days placebo
- Children treated for __ days were more likely to have clinical failure (34% vs 16%)
- Children w/ ___ AOM more likely to have failure (p<0.001)
- No increased resistance or ADRs found in __ day group

A
  • 5
  • bilateral
  • 10
26
Q

AOM - Duration: Over 2 years old

Exact effective duration is unknown

10 days of therapy for
◦ ___ or recurrent AOM
◦ ___ perforation
◦ < __ years

Shorter courses (5-7 days) may be used in children ≥ __ years of age

A
  • severe
  • TM
  • 2
  • 2
27
Q

Adjunctive Therapy

Analgesics
◦ ___ PO
◦ 10-15 mg/kg/dose Q4-6H (max 75 mg/kg/day)
◦ ___ PO
◦ 5-10 mg/kg/dose Q6-8H if older than 6 months
◦ Usually avoid alternating Q3H (confusing)

___ otic drops
◦ Do not use in ruptured TM or tubes
◦ May consider in children 2 and up
◦ 2-4 drops in affected ear TID-QID

A
  • APAP
  • Ibuprofen
  • lidocaine
28
Q

AOM - Not Routinely Recommended

Decongestants/ ___ – may be useful in URI, caution in < 4 years

___ – not routine, more common in acute otitis externa

Otikon otic solution – natural product, need more data

Sweet oil
◦ Avoid, can worsen bacterial growth

A
  • antihistamines
  • Dexamethasone
29
Q

Follow-up AOM

Within ___ for young infants with severe episode or children of any age with continuing pain

Within __ weeks for infants or young children with history of frequent recurrences

__ month after initial examination for children with only a sporadic episode of AOM

No follow-up may be necessary for ___ children

A
  • days
  • 2
  • 1
  • older
30
Q

Prevention AOM

Routine ___
◦ Pneumococcal
◦ Influenza

Reduction of preventable risk factors

Prophylaxis

___ tubes

A

vaccination
Tympanostomy

31
Q

Antibiotic Prophylaxis

Controversial → risk of ___ , ADRs, cost

May decrease ___ in children w/recurrent AOM
- Most benefit if ≥ __ episodes in previous year

A
  • resistance
  • frequency
  • 6
32
Q

Tympanostomy Tubes

Small ventilation tubes inserted through TM to provide drainage for eustachian
tubes

Indicated in ___ AOM
◦ __ or more episodes in < 6 mo
◦ __ or more episodes in < 12 mo

Treatment of uncomplicated otorrhea
◦ Topical ___ drops = (or better than) oral therapy
◦ Ofloxacin, ciprofloxacin

4-5 drops in affected ear BID x 5-7 days

Some controversy about steroids; combo drops commonly used

May consider watchful waiting, but should treat if does not resolve within ___ week

Topical quinolones can increase risk of ___ in patients without tubes

A
  • recurrent
  • 3
  • 4
  • quinolone
  • 1
  • performation
33
Q

Chronic Suppurative Otitis Media

CSOM = most ___ form

Characterized by ___ TM w/persistent drainage lasting > __ weeks

MRSA = most common isolate
◦ Others include MSSA, Pseudomonas, Proteus, anerobes, fungi

Can be complication of ___ tube

May result in abscess or ___ loss

Initial treatment ___ or ___ ear drops x 2 weeks

If treatment failure, culture is indicated (potentially requiring IV therapy or
surgery)

A
  • severe
  • perforated, 6
  • tympanostomy
  • hearing
  • ofloxacin, ciprofloxacin
34
Q

Acute Otitis Externa (Swimmer’s Ear)

  • Limited to ___ ear canal
  • Can be caused by trauma or trapped moisture - 5x more common in swimmers
  • Organisms are different (Pseudomonas, S. aureus; consider fungal if no improvement)

Treat with ear drops first; examples include
◦ ___ , neomycin, and hydrocortisone
◦ Ofloxacin
◦ ___ with hydrocortisone

A
  • external
  • Polymyxin B
  • Ciprofloxacin